Search Tag: Codagenix

Executive Health Management

2022 15 Dec

Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics announced that Paul Grint, MD, has been appointed Chairman of the Board of Directors. “We are delighted to welcome Paul to our Board of Directors. He is a biotechnology industry veteran who brings...Read more